| Date Checked | 2026-02-19 22:17:05 |
|---|---|
| Graham Number | (PB)nan vs (PE)0.00 |
| Over / Under Value Percentage | 0.00% vs 0.00% |
| Dividend Yield | 0.00% |
| Dividend Date | None |
| Symbol | MRNA |
| AssetType | Common Stock |
| Name | Moderna Inc |
| Description | Moderna, Inc. is a leading biotechnology company headquartered in Cambridge, Massachusetts, renowned for revolutionizing vaccine development through its proprietary messenger RNA (mRNA) technology. Gaining international acclaim for its pivotal role in producing one of the first effective COVID-19 vaccines, the company is actively broadening its research portfolio to encompass a diverse range of diseases, including cancer, rare disorders, cardiovascular diseases, and autoimmune conditions. With a robust pipeline and a strong commitment to scientific innovation, Moderna is positioned to transform healthcare by addressing critical unmet medical needs and enhancing patient outcomes worldwide. |
| CIK | 1682852 |
| Exchange | NASDAQ |
| Currency | USD |
| Country | USA |
| Sector | HEALTHCARE |
| Industry | BIOTECHNOLOGY |
| Address | 325 BINNEY STREET, CAMBRIDGE, MA, UNITED STATES, 02142 |
| OfficialSite | https://www.modernatx.com |
| FiscalYearEnd | December |
| LatestQuarter | 2025-09-30 |
| MarketCapitalization | 13230241000 |
| EBITDA | -3255000064 |
| PERatio | 0 |
| PEGRatio | 0 |
| BookValue | 23.86 |
| DividendPerShare | None |
| EPS | -8.06 |
| RevenuePerShareTTM | 5.76 |
| ProfitMargin | -1.396 |
| OperatingMarginTTM | -0.256 |
| ReturnOnAssetsTTM | -0.155 |
| ReturnOnEquityTTM | -0.293 |
| RevenueTTM | 2232000000 |
| GrossProfitTTM | -2401999872 |
| DilutedEPSTTM | -8.06 |
| QuarterlyEarningsGrowthYOY | -0.851 |
| QuarterlyRevenueGrowthYOY | -0.454 |
| AnalystTargetPrice | 36.6 |
| AnalystRatingStrongBuy | 2 |
| AnalystRatingBuy | 3 |
| AnalystRatingHold | 16 |
| AnalystRatingSell | 1 |
| AnalystRatingStrongSell | 2 |
| TrailingPE | - |
| ForwardPE | 32.47 |
| PriceToSalesRatioTTM | 5.93 |
| PriceToBookRatio | 1.503 |
| EVToRevenue | 4.656 |
| EVToEBITDA | 4.641 |
| Beta | 1.174 |
| 52WeekHigh | 45.4 |
| 52WeekLow | 22.28 |
| 50DayMovingAverage | 27.67 |
| 200DayMovingAverage | 27.41 |
| SharesOutstanding | 390734000 |
| SharesFloat | 364152000 |
| PercentInsiders | 7.413 |
| PercentInstitutions | 71.643 |
| ExDividendDate | None |
| naga | 1 |
| etoro | 1 |
| dateChecked | 2026-02-19 22:17:05 |
| fresh | 1 |